Investor New Enterprise Associates 14, L.P.
13D/G Filings

This page shows a list of all the recent 13D/G filings made by New Enterprise Associates 14, L.P. . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-19 13D/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 102,478,672 4
2025-02-14 13G/A TUYA / Tuya Inc. - Depositary Receipt (Common Stock) 114,084,633 39,457,733
2025-01-07 13D/A NN / NextNav Inc. 8,189,156 75,627
2024-11-01 13G/A TUYA / Tuya Inc. - Depositary Receipt (Common Stock) 119,019,273 114,084,633
2024-05-16 13D/A SYBX / Synlogic, Inc. 2,922,774 2,922,774
2024-05-15 13D/A ZFOX / ZeroFox Holdings, Inc.
2024-05-10 13D/A NN / NextNav Inc. 8,189,156
2024-05-06 13D/A CSBR / Champions Oncology, Inc. 29,062,500 1,713,720
2024-04-02 13D/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 102,478,672 102,478,672
2023-10-13 13D/A SYBX / Synlogic, Inc. 4,228,940 2,922,774
2023-03-30 13D/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 98,921,868 102,478,672
2023-02-03 13G/A TUYA / Tuya Inc. - Depositary Receipt (Common Stock) 123,284,633 119,019,273
2023-01-09 13D/A OYST / Oyster Point Pharma Inc 5,925,287
2022-11-21 13D/A OYST / Oyster Point Pharma Inc 5,925,287 5,925,287
2022-08-12 13D ZFOX / ZeroFox Holdings, Inc. 18,068,513
2022-05-24 13D/A IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 1,920,849
2022-04-25 13D/A IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 3,695,192 1,920,849
2022-02-15 13G TUYA / Tuya Inc. - Depositary Receipt (Common Stock) 123,284,633
2022-01-10 13D/A IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 4,013,995 3,695,192
2022-01-05 13D/A LUMO / Lumos Pharma, Inc. 524,030
2021-12-01 13D / NEXTNAV INC 8,189,156
2021-11-22 13D/A CSPR / Casper Sleep Inc 6,222,412 6,222,502
2021-03-11 13D/A TCON / TRACON Pharmaceuticals, Inc. 3,568,753
2021-02-12 13G/A SURF / Surface Oncology Inc 3,312,877
2020-12-10 13D/A MRSN / Mersana Therapeutics, Inc. 3,961,232
2020-11-19 13D/A MRSN / Mersana Therapeutics, Inc. 5,963,114 3,961,232
2020-09-22 13D/A MRSN / Mersana Therapeutics, Inc. 5,963,114 5,963,114
2020-09-21 13D/A MRSN / Mersana Therapeutics, Inc. 7,961,912 5,963,114
2020-04-24 13D/A MRSN / Mersana Therapeutics, Inc. 11,903,072 7,961,912
2020-04-01 13D LUMO / Lumos Pharma, Inc. 524,030 524,030
2020-03-31 13D LUMO / Lumos Pharma, Inc. 524,030
2020-03-20 13D IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF 4,013,995
2020-02-20 13D CSPR / Casper Sleep Inc 6,222,412
2020-02-13 13G/A ESTC / Elastic N.V. 6,353,498
2020-02-13 13G GRTX / Galera Therapeutics, Inc. 4,358,042
2020-02-13 13G/A MDB / MongoDB, Inc. 3,078,185
2020-02-13 13G/A SURF / Surface Oncology Inc 3,312,877 3,312,877
2019-11-08 13D OYST / Oyster Point Pharma Inc 5,925,287
2019-03-14 13D/A MRSN / Mersana Therapeutics, Inc. 11,903,072 11,903,072
2019-03-13 13D/A MRSN / Mersana Therapeutics, Inc. 11,903,072
2019-02-13 13G SURF / Surface Oncology Inc 3,312,877
2019-02-13 13G ESTC / Elastic N.V. 6,353,498
2019-02-12 13G/A APPN / Appian Corporation 2,724,202
2018-09-17 13D ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 72,493,635 98,921,868
2018-05-14 13D/A MULE / Mulesoft, Inc. 16,115,887
2018-04-03 13D/A TCON / TRACON Pharmaceuticals, Inc. 2,758,039 3,568,753
2018-03-29 13D MULE / Mulesoft, Inc. 16,115,887 16,115,887
2018-02-12 13G MDB / MongoDB, Inc. 3,078,185
2018-02-01 13D/A SYBX / Synlogic, Inc. 3,818,940 4,228,940
2018-01-29 13G APPN / Appian Corporation 2,724,202
2018-01-29 13G/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 59,432,229 72,493,635
2018-01-29 13G MULE / Mulesoft, Inc. 16,115,887
2017-09-07 13D/A SYBX / Synlogic, Inc. 2,971,517 3,818,940
2017-07-11 13D MRSN / Mersana Therapeutics, Inc. 8,140,138
2017-05-16 13D/A SYBX / Synlogic, Inc. 2,971,517 2,971,517
2017-02-14 13G/A ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 59,432,229 59,432,229
2017-02-06 13G/A AVTX / Avalo Therapeutics, Inc. 594,245
2016-12-08 13D/A TCON / TRACON Pharmaceuticals, Inc. 2,758,039
2016-11-21 13D/A LOXO / Loxo Oncology, Inc. 1,294,420
2016-09-13 13D/A LOXO / Loxo Oncology, Inc. 1,294,420
2016-02-10 13G ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) 59,432,229
2016-02-01 13G AVTX / Avalo Therapeutics, Inc. 594,245
2016-02-01 13G/A NVRO / Nevro Corp.
2015-10-14 13D SYBX / Synlogic, Inc. 2,971,517
2015-03-24 13D CSBR / Champions Oncology, Inc. 29,062,500
2015-02-11 13D TCON / TRACON Pharmaceuticals, Inc. 1,888,474
2015-02-09 13G NVRO / Nevro Corp. 1,367,649
2014-08-12 13D LOXO / Loxo Oncology, Inc. 1,789,420